All4NutraNo products in the cart.
All4NutraStartseite » Topical Excipient » Page 2
PRESS RELEASE, 21. August 2025 From 2027, the cosmetics industry will be entering a new chapter: cyclopentasiloxane and other cyclic...
Drug Delivery and Biomedical Applications of Porous Silicon-Based Nanocarriers See the new book, edited by Rajendra Awasthi, Santosh Kumar Singh,...
Abstract This study investigates the influence of phospholipid saturation by comparing hydrogenated soy phosphatidylcholine (HSPC) and egg yolk phosphatidylcholine (EPC)...
PRESS RELEASE Paris, October 27, 2025: The dermo-pharmaceutical market, valued at over $21 billion, is experiencing significant growth 1 with...
Abstract Tacrolimus (TAC), a calcineurin inhibitor used topically for T-cell-mediated skin diseases, faces challenges due to poor solubility and limited...
The oral hygiene market is experiencing rapid evolution, driven by increased consumer awareness, demand for gentle and effective products, and...
Join us in the upcoming webinar for a comprehensive guide to navigating the challenging aspects of topical drug formulation, focusing...
Abstract Ketoconazole (KTZ) functions by suppressing the propagation of ergosterol, an essential element of the fungal cell membrane. However, its...
Abstract Psoriasis is a hereditary, autoimmune, chronic illness that influences the immune system and can have both cutaneous and systemic...
Abstract The World Psoriasis Day consortium estimates that 2–3% of individuals worldwide suffer from psoriasis. Budesonide (BDS) is a potent...
Copyright: PharmaExcipients AG